GlassScriptPhysician profile
David Alan Kirkman
NPI 1285624478
$8,117.99
in general payments reported to CMS, 2019-2025
20 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $124 · 2021: $139 · 2022: $232 · 2023: $445 · 2024: $6,837 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $1,021 · Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $1,020.73 |
| Food and Beverage | $474.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,080.31 | 2023-2024 | Da Vinci Surgical System |
| Abbvie INC. | $318.20 | 2020-2025 | |
| Astellas Pharma US INC | $71.85 | 2019-2025 | Veozah |
| Merck Sharp & Dohme LLC | $68.09 | 2019-2022 | |
| Hologic Sales and Service, LLC | $66.20 | 2020-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Boston Scientific Corporation | $65.53 | 2020-2021 | |
| Coopersurgical, INC. | $55.26 | 2019-2025 | Paragard T 380a |
| Ethicon US, LLC | $52.45 | 2019-2024 | Megadyne, Stratafix, Dermabond Prineo |
| Organon LLC | $47.26 | 2021-2024 | Nexplanon |
| Sumitomo Pharma America, INC. | $42.30 | 2024-2025 | Myfembree |
| Conmed Corporation | $40.65 | 2023-2025 | Airseal |
| Bayer Healthcare Pharmaceuticals INC. | $38.85 | 2019-2022 | |
| Aspira Women'S Health INC | $32.77 | 2021 | |
| Exeltis, USA INC. | $30.27 | 2023 | Slynd |
| Allergan, INC. | $26.84 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $21.88 | 2022 | |
| Coloplast Corp | $18.97 | 2025 | |
| Dexcom, INC. | $15.01 | 2025 | Dexcom G6 Transmitter |
| Agile Therapeutics, INC. | $14.51 | 2021 | |
| Meditrina | $10.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kirkman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.